Spanish eTIPS for Early Therapy in Perinatal Stroke (eTIPS-ES)

May 18, 2026 updated by: University of Castilla-La Mancha

Spanish eTIPS: Translation, Cross-Cultural Adaptation, and Pilot Randomized Feasibility Study of Early Therapy in Perinatal Stroke for Spanish-Speaking Families

This study adapts and evaluates the Spanish version of eTIPS, an early home-based therapy program for infants at risk of unilateral cerebral palsy after perinatal stroke. The project has three parts: translation and cultural adaptation of the original materials, a pilot randomized feasibility study comparing eTIPS with usual care, and a qualitative study exploring family experiences, barriers, and facilitators to using the program at home.

In the first part, the study team will translate and culturally adapt the eTIPS materials for Spanish-speaking families, review them with experts, and test whether the content is clear, relevant, and usable. In the second part, families with infants diagnosed with perinatal stroke or at high risk of unilateral cerebral palsy will be assigned to either the eTIPS program or usual clinical care to assess recruitment, retention, adherence, safety, acceptability, and preliminary effects on infant motor development and family outcomes. In the third part, caregivers in the intervention group will take part in interviews to better understand how the program fits into daily life and what could improve future implementation.

Study Overview

Detailed Description

This is a mixed-methods study designed to translate, culturally adapt, and evaluate the Spanish version of eTIPS, an early, parent-delivered therapy program originally developed for infants with perinatal stroke and risk of unilateral cerebral palsy. The project follows a staged approach with three linked phases: Phase I, translation and cross-cultural adaptation of the intervention materials; Phase II, a pilot randomized feasibility study; and Phase III, a qualitative study of family experiences and implementation.

Phase I will include forward translation, back-translation, expert review, and feedback from caregivers and professionals to ensure semantic, conceptual, and cultural equivalence of the Spanish materials. Phase II will randomize eligible infants to eTIPS or usual care, with the intervention delivered by caregivers in the home environment and supported by the research team. Outcomes in this phase will focus on feasibility and process measures such as eligibility, recruitment, consent, retention, adherence, usability, safety, and fidelity, as well as exploratory infant and caregiver outcomes.

The infant assessments may include measures of hand function, motor development, neurological status, and stroke-related outcomes, while caregiver outcomes may include well-being, stress, competence, and bonding. Phase III will use semi-structured interviews and thematic analysis to explore how caregivers experience the intervention in everyday routines, including perceived benefits, barriers, facilitators, and suggestions for improvement. The results will be used to refine the Spanish eTIPS program and inform the design of a future definitive multicenter trial.

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Infants with confirmed unilateral perinatal stroke diagnosis by neuroimaging, identified within first 3 months of life
  • Age at recruitment ≤3 months postnatal (intervention starts when clinically stable, maximum term-equivalent age)
  • Written informed consent from parents/legal guardians

Exclusion Criteria:

  • Known progressive neurodegenerative disorder or severe medical comorbidity preventing participation (e.g., ventilation-dependent respiratory failure)
  • Extensive bilateral intracerebral lesion making lateralized intervention irrelevant
  • Concurrent participation in another clinical trial with interfering treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: eTIPS Intervention
Participants assigned to this arm will receive the Spanish-adapted eTIPS program, a parent-delivered, home-based early intervention for infants with perinatal stroke or risk of unilateral cerebral palsy. Families will receive training, adapted materials, and ongoing support to integrate lateralized therapeutic activities into daily routines from enrollment until corrected age 6 months.
Parent-delivered, home-based early therapy for infants with perinatal stroke or risk of unilateral cerebral palsy. Families receive the Spanish-adapted eTIPS materials, training, and ongoing support to integrate lateralized therapeutic activities into daily routines from enrollment until corrected age 6 months. The intervention is delivered alongside usual clinical care
Active Comparator: Usual Care
Participants assigned to this arm will receive usual clinical care according to local practice, including standard neonatal, neurological, and rehabilitation follow-up. This arm serves as the comparator for feasibility, acceptability, and exploratory outcome assessment
Standard neonatal, neurological, and rehabilitation follow-up according to local clinical practice. Includes routine pediatric neurology monitoring, periodic neurological evaluations to track motor development and detect early signs of unilateral cerebral palsy, and referral to pediatric rehabilitation with physiotherapy sessions (1 session/week or biweekly, 30-45 minutes) focused on mobilizations, muscle tone control, joint range maintenance, general sensory stimulation, and basic postural guidelines.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruitment Rate
Time Frame: From identification to enrollment (baseline)
Proportion of eligible infants identified in neonatology/pediatric neurology who accept participation. Success criterion: ≥70% acceptance rate
From identification to enrollment (baseline)
Retention Rate
Time Frame: 6 months (end of intervention)
Percentage of families completing the 6-month follow-up. Success criterion: ≥80% retention
6 months (end of intervention)
Adherence Rate
Time Frame: Daily/weekly during 6 months
Days per week and minutes per week of practice recorded in digital diary/app. Success criterion: ≥70% practice days
Daily/weekly during 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Usability (SUS Score)
Time Frame: Post-intervention (6 months)
System Usability Scale (SUS) score for materials and platform. Target: ≥70 points
Post-intervention (6 months)
Safety
Time Frame: Throughout 6 months
Adverse events or incidents related to intervention (excessive fatigue, persistent rejection, feeding worsening)
Throughout 6 months
Parental Satisfaction
Time Frame: Post-Intervention (6 months)
Likert-scale questionnaire on experience, confidence gained, and recommendation of program
Post-Intervention (6 months)
Fidelity
Time Frame: Monthly during 6 months
Professional observation of correct eTIPS technique application during scheduled visits
Monthly during 6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hand Assessment for Infants (HAI)
Time Frame: Baseline, 3 months, 6 months, 12 months
Video-based observational assessment of unimanual and bimanual hand function
Baseline, 3 months, 6 months, 12 months
Infant Motor Profile (IMP)
Time Frame: Baseline, 3 months, 6 months
Structured observation of fine and gross motor patterns
Baseline, 3 months, 6 months
Paediatric Stroke Outcome Measure (PSOM)
Time Frame: Baseline, 3 months, 6 months
Neurological and functional sequelae monitoring post-stroke
Baseline, 3 months, 6 months
Bayley Scales of Infant Development (BSID-IV)
Time Frame: Baseline, 3 months, 6 months, 12 months
Standardized assessment of cognitive, motor and socio-emotional development in children from 1 to 42 months.
Baseline, 3 months, 6 months, 12 months
Hammersmith Infant Neurological Examination (HINE)
Time Frame: Baseline, 3 months, 6 months
Standardized neurological assessment for infants 2-24 months evaluating motor and neurological development
Baseline, 3 months, 6 months
Parenting Sense of Competence (PSOC)
Time Frame: Baseline, 3 months, 6 months
Questionnaire measuring parental perception of competence in child care and education
Baseline, 3 months, 6 months
Warwick-Edinburgh Mental Well-Being Scale (WEMWBS)
Time Frame: Baseline, 3 months, 6 months
Brief scale measuring psychological and emotional well-being in primary caregivers
Baseline, 3 months, 6 months
Family Empowerment Scale
Time Frame: Baseline, 6 months
Measures family perception of empowerment in caring for and supporting child with special needs
Baseline, 6 months
Edinburgh Postnatal Depression Scale (EPDS)
Time Frame: Baseline, 3 months, 6 months
10-item self-report screening for postpartum depressive symptoms (cut-off ≥10/12). Spanish validated
Baseline, 3 months, 6 months
Parenting Stress Index - Short Form (PSI-SF)
Time Frame: Baseline, 3 months, 6 months
36-item measure of parental stress across 3 subscales: Parental Distress, Parent-Child Dysfunctional Interaction, Difficult Child
Baseline, 3 months, 6 months
Postpartum Bonding Questionnaire (PBQ)
Time Frame: Baseline, 3 months, 6 months
25-item questionnaire assessing mother-infant bonding quality. Detects rejection, anger, infantification (cut-off ≥12 factor 1)
Baseline, 3 months, 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

July 31, 2028

Study Completion (Estimated)

December 31, 2028

Study Registration Dates

First Submitted

May 18, 2026

First Submitted That Met QC Criteria

May 18, 2026

First Posted (Actual)

May 26, 2026

Study Record Updates

Last Update Posted (Actual)

May 26, 2026

Last Update Submitted That Met QC Criteria

May 18, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No plan to share individual participant data (IPD). Data will be stored securely at Universidad de Castilla-La Mancha following Spanish and EU data protection regulations (RGPD/LOPDGDD). Aggregate results will be published in peer-reviewed journals.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Perinatal Stroke and Risk of Unilateral Cerebral Palsy

Subscribe